Notes_NNS to_TO the_DT consolidated_JJ accounts_NNS Unilever_NNP Group_NNP 16_CD Trade_NNP and_CC other_JJ creditors_NNS million_CD million_CD 2003_CD 2002_CD Restated_VBN Due_JJ within_IN one_CD year_NN :_: Trade_NNP creditors_NNS 3_CD 707_CD 4_CD 341_CD Social_NNP security_NN and_CC sundry_JJ taxes_NNS 346_CD 458_CD Accruals_NNPS and_CC deferred_VBN income_NN 2_CD 548_CD 2_CD 889_CD Taxation_NNP on_IN profits_NNS 728_CD 857_CD Dividends_NNPS 1_CD 125_CD 1_CD 138_CD Others_NNS 1_CD 186_CD 1_CD 335_CD 9_CD 640_CD 11_CD 018_CD Due_JJ after_IN more_JJR than_IN one_CD year_NN :_: Accruals_NNS and_CC deferred_JJ income_NN 207_CD 147_CD Taxation_NNP on_IN profits_NNS 330_CD 365_CD Others_NNS 127 129 664 641_CD Total_JJ trade_NN and_CC other_JJ creditors_NNS 10_CD 304_CD 11_CD 659_CD 17_CD Pensions_NNS and_CC similar_JJ obligations_NNS Description_NN of_IN Plans_NNS In_IN most_JJS countries_NNS the_DT Group_NNP operates_VBZ dened_VBN benefit_NN pension_NN plans_NNS based_VBN on_IN employee_NN pensionable_JJ remuneration_NN and_CC length_NN of_IN service_NN ._.
The_DT majority_NN of_IN these_DT plans_NNS are_VBP externally_RB funded_VBN ._.
The_DT Group_NNP also_RB provides_VBZ other_JJ post-employment_NN benets_NNS ,_, mainly_RB post-employment_JJ medical_JJ plans_NNS in_IN the_DT United_NNP States_NNPS ._.
These_DT plans_NNS are_VBP predominantly_RB unfunded_JJ ._.
The_DT Group_NNP also_RB operates_VBZ a_DT number_NN of_IN dened_VBN contribution_NN plans_NNS ,_, the_DT assets_NNS of_IN which_WDT are_VBP held_VBN in_IN external_JJ funds_NNS ._.
Accounting_NNP policies_NNS With_IN effect_NN from_IN 1_CD January_NNP 2003_CD ,_, the_DT Group_NNP accounts_NNS for_IN pensions_NNS and_CC similar_JJ benets_NNS under_IN the_DT United_NNP Kingdom_NNP Financial_NNP Reporting_NNP Standard_NNP 17_CD FRS_NNP 17_CD ._.
Figures_NNS for_IN prior_JJ years_NNS have_VBP been_VBN restated_VBN ._.
In_IN accordance_NN with_IN the_DT new_JJ standard_NN ,_, the_DT operating_NN and_CC nancing_NN costs_NNS of_IN dened_VBN benefit_NN plans_NNS are_VBP recognized_VBN separately_RB in_IN the_DT profit_NN and_CC loss_NN account_NN :_: service_NN costs_NNS are_VBP systematically_RB spread_VBN over_IN the_DT service_NN lives_NNS of_IN employees_NNS ,_, and_CC nancing_VBG costs_NNS are_VBP recognized_VBN in_IN the_DT periods_NNS in_IN which_WDT they_PRP arise_VBP ._.
Variations_NNS from_IN expected_VBN costs_NNS ,_, arising_VBG from_IN the_DT experience_NN of_IN the_DT plans_NNS or_CC changes_NNS in_IN actuarial_JJ assumptions_NNS ,_, are_VBP recognized_VBN immediately_RB in_IN the_DT statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS ._.
The_DT costs_NNS of_IN individual_JJ events_NNS such_JJ as_IN past_JJ service_NN benefit_NN enhancements_NNS ,_, settlements_NNS and_CC curtailments_NNS are_VBP recognized_VBN immediately_RB in_IN the_DT profit_NN and_CC loss_NN account_NN ._.
The_DT liabilities_NNS and_CC ,_, where_WRB applicable_JJ ,_, the_DT assets_NNS of_IN dened_VBN benefit_NN plans_NNS are_VBP recognized_VBN at_IN fair_JJ value_NN in_IN the_DT balance_NN sheet_NN ._.
The_DT charges_NNS to_TO the_DT profit_NN and_CC loss_NN account_NN for_IN dened_VBN contribution_NN plans_NNS are_VBP the_DT company_NN contributions_NNS payable_JJ and_CC the_DT assets_NNS of_IN such_JJ plans_NNS are_VBP not_RB included_VBN in_IN the_DT Group_NNP balance_NN sheet_NN ._.
All_DT dened_VBN benefit_NN plans_NNS are_VBP subject_JJ to_TO regular_JJ actuarial_JJ review_NN using_VBG the_DT projected_VBN unit_NN method_NN ,_, either_CC by_IN external_JJ consultants_NNS or_CC by_IN actuaries_NNS employed_VBN by_IN Unilever_NNP ._.
Group_NNP policy_NN is_VBZ that_IN the_DT most_RBS important_JJ plans_NNS representing_VBG over_IN 75_CD %_NN of_IN the_DT dened_VBN benefit_NN liabilities_NNS are_VBP formally_RB valued_VBN every_DT year_NN and_CC other_JJ principal_JJ plans_NNS accounting_VBG for_IN approximately_RB a_DT further_JJ 15_CD %_NN of_IN liabilities_NNS have_VBP their_PRP$ liabilities_NNS updated_VBN each_DT year_NN ._.
Group_NNP policy_NN for_IN other_JJ plans_NNS requires_VBZ a_DT full_JJ actuarial_JJ valuation_NN at_IN least_JJS every_DT three_CD years_NNS ._.
Asset_NNP values_NNS for_IN all_DT plans_NNS are_VBP updated_VBN every_DT year_NN ._.
Prior_RB to_TO 1_CD January_NNP 2003_CD ,_, the_DT Group_NNP accounted_VBD for_IN pensions_NNS and_CC similar_JJ obligations_NNS under_IN the_DT UK_NNP accounting_NN standard_NN SSAP_NNP 24_CD ._.
The_DT objective_NN of_IN that_DT standard_NN was_VBD to_TO spread_VB pension_NN costs_NNS systematically_RB over_IN the_DT service_NN lives_NNS of_IN employees_NNS and_CC for_IN the_DT regular_JJ costs_NNS to_TO be_VB a_DT reasonably_RB stable_JJ percentage_NN of_IN pay_NN ._.
In_IN line_NN with_IN the_DT accounting_NN objectives_NNS ,_, assumptions_NNS were_VBD generally_RB set_VBN reecting_VBG long-term_JJ expectations_NNS and_CC with_IN asset_NN values_NNS smoothed_VBD relative_JJ to_TO market_NN values_NNS ._.
Under_IN SSAP_NNP 24_CD ,_, unlike_IN FRS_NNP 17_CD ,_, all_DT components_NNS of_IN pension_NN expense_NN were_VBD recognized_VBN in_IN operating_NN profit_NN ._.
Had_VBD the_DT Group_NNP continued_VBD to_TO account_VB for_IN pensions_NNS and_CC similar_JJ obligations_NNS in_IN 2003_CD under_IN SSAP_NNP 24_CD ,_, the_DT charge_NN to_TO operating_VBG profit_NN would_MD have_VB been_VBN 561_CD million_CD 2002_CD :_: 416_CD million_CD :_: 2001_CD :_: 326_CD million_CD ,_, there_EX would_MD have_VB been_VBN no_DT charge_NN to_TO nancing_VBG cost_NN and_CC the_DT charge_NN to_TO profit_NN after_IN tax_NN would_MD have_VB been_VBN 361_CD million_CD 2002_CD :_: 261_CD million_CD :_: 2001_CD :_: 205_CD million_CD ._.
No_DT gains_NNS or_CC losses_NNS would_MD have_VB been_VBN recognized_VBN in_IN the_DT statement_NN of_IN recognized_VBN gains_NNS and_CC losses_NNS ._.
Healthcare_NNP In_IN December_NNP 2003_CD the_DT Medicare_NNP Prescription_NNP Drug_NNP ,_, Improvement_NNP and_CC Modernisation_NNP Act_NNP became_VBD law_NN in_IN the_DT US_NNP ._.
Under_IN the_DT provisions_NNS of_IN this_DT Act_NNP ,_, the_DT Groups_NNS US_NNP healthcare_NN benefit_NN plan_NN will_MD be_VB able_JJ to_TO benefit_VB from_IN a_DT subsidy_NN towards_IN the_DT cost_NN of_IN prescription_NN drugs_NNS ._.
In_IN order_NN to_TO be_VB eligible_JJ to_TO receive_VB this_DT subsidy_NN it_PRP is_VBZ expected_VBN that_IN we_PRP will_MD need_VB to_TO make_VB minor_JJ changes_NNS to_TO the_DT rules_NNS of_IN the_DT Groups_NNS US_NNP plan_NN ._.
Until_IN these_DT changes_NNS are_VBP made_VBN ,_, no_DT recognition_NN of_IN the_DT drug_NN subsidy_NN is_VBZ reected_VBN in_IN the_DT Group_NNP accounts_NNS ._.
Preliminary_JJ estimates_NNS indicate_VBP that_IN once_RB eligible_JJ ,_, the_DT Groups_NNS liability_NN will_MD reduce_VB by_IN approximately_RB 55_CD million_CD and_CC the_DT ongoing_JJ service_NN cost_NN would_MD reduce_VB by_IN an_DT immaterial_JJ amount_NN ._.
Unilever_NNP Annual_JJ Report_NNP &_CC Accounts_NNPS and_CC Form_NN 20-F_JJ 2003_CD 99_CD
